Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Expert Review of Anticancer Therapy|September 13, 2022
Targeting the DNA damage response in pediatric malignanciesJenna M Gedminas, Theodore W LaetschRadiology Case Reports|February 24, 2026
Cervical vertebra plana secondary to Ewing sarcoma: A case reportRichie Zhang, Mason C Vaillancourt, Theodore S Donta, et al.Oncogenesis|April 30, 2020
Desmoplastic small round cell tumor is dependent on the EWS-WT1 transcription factorJenna M Gedminas, Maggie H Chasse, Mitchell McBrairty, et al.Molecular Cancer Therapeutics|June 3, 2022
Lurbinectedin Inhibits the EWS-WT1 Transcription Factor in Desmoplastic Small Round Cell TumorJenna M Gedminas, Rebecca Kaufman, Elissa A Boguslawski, et al.Cancer Research Communications|June 6, 2025
Histone Deacetylase Inhibitors Target DNA Replication Regulators and Replication Stress in Ewing Sarcoma CellsStacia L Koppenhafer, Elizabeth L Geary, Mary V Thomas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent MannerMatt L Harlow, Maggie H Chasse, Elissa A Boguslawski, et al.Nature Communications|February 16, 2026
Mithramycin alters EWS::FLI1 DNA binding and RNA polymerase II processivity to inhibit nascent transcriptionRebecca Kaufman, Guillermo Flores, Elissa A Boguslawski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2024
Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing SarcomaJennifer Jess, Katie M Sorensen, Elissa A Boguslawski, et al.Nature Medicine|April 16, 2026
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trialPatrick J Grohar, Rachel Heise, Mary Frances Wedekind, et al.Pageof 1